<DOC>
	<DOCNO>NCT00003734</DOCNO>
	<brief_summary>RATIONALE : Androgens stimulate growth prostate cancer cell . Hormone therapy use triptorelin flutamide may fight cancer reduce production androgen . It yet know whether give hormone therapy 4 month effective give therapy 8 month prior radiation therapy prostate cancer . PURPOSE : Randomized phase III trial study effectiveness combination hormone therapy 4 8 month follow radiation therapy treat patient prostate cancer .</brief_summary>
	<brief_title>Combination Hormone Therapy Followed Radiation Therapy Treating Patients With Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare efficacy 4 month vs 8 month luteinizing hormone-releasing hormone ( LHRH ) agonist therapy combine antiandrogen therapy prior radiotherapy , term disease-free survival overall survival , patient stage I-IV localized invasive prostate cancer . OUTLINE : This randomize study . Patients randomize one two treatment arm . All patient receive triptorelin IM month oral flutamide three time daily meal . Patients randomized arm I receive therapy regimen 4 month . Patients randomize arm II receive therapy regimen 8 month . All patient undergo radiotherapy 5 day week 7 week within 2 month last injection triptorelin within 1 month last oral flutamide tablet . Patients follow every 3 month radiotherapy . PROJECTED ACCRUAL : A total 276 patient ( 138 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Flutamide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm invasive adenocarcinoma prostate Stage I II ( PSA great 20 Gleason score least 7 ) OR Stage III IV ( PSA , Gleason ) Histologically confirm benign nodal status No distant metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No prior malignancy except nonmelanoma skin cancer No uncontrolled illness would prevent compliance PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : No prior concurrent hormonal therapy Radiotherapy : Not specify Surgery : No prior treatment transurethral prostatectomy No prior orchiectomy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>